Garcia I, Beyens M N, Gauchoux R, Guy C, Ollagnier M
Centre de Pharmacovigilance et de Renseignements sur le Médicament, C.H.U. de St-Etienne, Hôpital de Bellevue, Boulevard Pasteur, 42055 Saint-Etienne, France.
Therapie. 2000 Sep-Oct;55(5):605-11.
A prospective drug prescription and descriptive study was undertaken in a sample of 214 pregnant women in the department of the Loire. This population was randomized using pregnancy declaration files from the French Health Care Centre. Data recording was retrospective. A total of 2064 drugs have been prescribed; 90 per cent of women received at least one drug during the course of pregnancy with an average of 11.5 drugs per woman. Antispasmodics are mainly prescribed in the first trimester while vitamins, mineral supplements, antianemics and vasoactive agents are found in the third trimester. Prescriptions do not rise with age but increase in urban areas. Use of PDD/DDD (Prescribed Daily Dose/Defined Daily Dose) is an estimation of prescription customs. For ketoprofen, it is 1.6 in the last trimester, although this drug is contra-indicated.
在卢瓦尔省对214名孕妇进行了一项前瞻性药物处方和描述性研究。该人群通过法国医疗保健中心的妊娠申报档案进行随机分组。数据记录是回顾性的。总共开出了2064种药物;90%的女性在孕期至少服用过一种药物,每位女性平均服用11.5种药物。解痉药主要在孕早期开具,而维生素、矿物质补充剂、抗贫血药和血管活性药物则在孕晚期开具。处方量并不随年龄增长而增加,但在城市地区有所增加。使用PDD/DDD(规定日剂量/限定日剂量)是对处方习惯的一种估计。对于酮洛芬,在孕晚期其值为1.6,尽管该药物是禁忌的。